Methicillin-resistant Staphylococcus (MRSA)
Vancomycin-resistant Enterococci (VRE)
Our Rates
MRSA Rate
The method of calculation of the MRSA bacteraemia infection rate for the reporting period (on a quarterly basis) is:
Number of nosocomial patients with laboratory identification of MRSA bacteraemia X 1000
Total # of patient days (quarterly)
Where the numerator is the total number of newly identified cases for MRSA bacteraemia associated with the reporting facility, for the reporting period. The denominator is the total number of in-patient days for the reporting period. There are no exclusion criteria.
VRE Rate
The method of calculation of the VRE bacteraemia infection rate for the reporting period (on a quarterly basis) is:
Number of nosocomial patients with laboratory identification of VRE bacteraemia X 1000
Total # of patient days (quarterly)
Where the numerator is the total number of newly identified cases for VRE bacteraemia associated with the reporting facility, for the reporting period. The denominator is the total number of in-patient days for the reporting period. There are no exclusion criteria.
|
Q4 2019/2020 |
Q1 2020/2021 |
Q2 2020/2021 |
Q3 2020/2021 |
Q4 2020/2021 |
|
Number of new MRSA cases
|
1
|
2
|
10
|
10
|
1 |
| MRSA Rate |
0.07 |
0.40 |
0.67 |
0.69
|
0.07 |
|
Number of new VRE cases
|
0 |
0
|
0
|
0
|
0 |
| VRE Rate |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Q1 2021/2022 | Q2 2021/2022 | Q3 2021/2022 | Q4 2021/2022 |
| Number of new MRSA cases | 0 | 0 | 1 | 0 |
| MRSA Rate | 0.00 | 0.00 | 0.06 | 0.00
|
| Number of new VRE cases | 0 | 0 | 0 | 0 |
| VRE Rate | 0.00 | 0.00 | 0.00 | 0.00 |
| Q1 2022/2023 | Q2 2022/2023 | Q3 2022/2023 | Q4 2022/2023 |
| Number of new MRSA cases | 0 | 0 | 0 |
|
| MRSA Rate | 0.00 | 0.00 | 0.00 |
|
| Number of new VRE cases | 0 | 0 | 0 |
|
| VRE Rate | 0.00 | 0.00 | 0.00 |
|